Everything that moved since yesterday's close, from the session, the filings and the nightly score. Comes back fresh every evening.
As of the 2026-09-03 close.
Consolidated, trailing twelve months unless marked. The first six are fixed; the rest are your quick ratios.
End-of-day prices as of 2026-09-03, adjusted for splits and bonuses.
Three independent estimates from filed numbers, recomputed after every filing and close. Model output for study, not a target or a call.
Every statement from the exchange filing, consolidated or standalone. Industry medians come from the served universe, ownership from the shareholding pattern, and any cell whose input isn't on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Sep 5, 2026
| ₹ Cr | Jun2026Latest | YoYlatest |
|---|---|---|
| Sales | 408 | — |
| Expenses | 308 | — |
| Operating profit | 101 | — |
| OPM % | 24.6% | — |
| Other income | 3.10 | — |
| Interest | 10.7 | — |
| Depreciation | 17.1 | — |
| Profit before tax | 75.9 | — |
| Tax % | 30.5% | — |
| Net profit | 52.7 | — |
| EPS (₹) | 5.21 | — |
No annual filings yet
No full-year results for MOLBIO on the consolidated basis yet.
No balance sheet yet
Balance-sheet items come from the annual filing — none on record yet.
No cash flow yet
Cash-flow statements come from the annual filing — none on record yet.
| Metric | MOLBIO | Sector median | Read |
|---|---|---|---|
| P/E (TTM) | — | 34.3× | — |
| P/B | — | 3.2× | — |
| ROE (TTM) | — | 10.1% | — |
| ROCE (TTM) | — | 13.3% | — |
| Debt / equity | — | 0.11 | — |
| Div yield (TTM) | — | — | — |
Medians across Healthcare’s universe: returns and leverage from the latest filings, P/E and P/B priced at the last close; a lender’s ROCE and D/E read “—” by design.
| Metric | Value | Read |
|---|---|---|
| Revenue growthYoY · latest Q | — | — |
| EBIT marginlatest FY | — | — |
| Debt / equitylatest filing | — | — |
| Interest coveragelatest FY | — | — |
| Promoter holdingAug 26 | 41.3% | — |
| Pledged sharesof promoter holding | — | — |
Reads are fixed rule thresholds on filed values, descriptive context only: EBIT margin = (PBT + interest) ÷ revenue vs the sector median (same basis), interest coverage = (PBT + interest) ÷ interest at 1.5× / 3×, D/E at 0.3 / 1.0. Promoter holding and pledge come from the latest shareholding pattern where ingested.
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
15 peers in Healthcare Equipment & Supplies. Valuation against quality on one chart, then every metric head-to-head with best-in-class highlighted.
| Company | MCap ₹Cr⇅ | P/E⇅ | P/B⇅ | ROE %⇅ | ROCE %⇅ | EBIT %⇅ | Rev YoY⇅ | PAT YoY⇅ | D/E⇅ | 1Y ret⇅ | Score⇅ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOLBIOMolbio Diagnostics Limited | — | — | — | — | — | — | — | — | — | — | — | |
| POLYMEDPoly Medicure Limited | 17,256 | 54.8 | 5.6 | 10.1 | 14.2 | 23.5 | 12.3 | -5.3 | 0.11 | -16.3 | 54 | |
| TARSONSTarsons Products Limited | 1,785 | 160.6 | 2.8 | 1.7 | 4.5 | 10.5 | 7.7 | -51.9 | 0.60 | 4.0 | 41 | |
| QLINEQ-LINE BIOTECH LIMITED | 1,041 | 18.4 | — | — | — | 18.8 | 54.7 | -17.6 | — | — | 62° | |
| FISCHERFischer Medical Ventures Limited | 2,359 | 15.0 | 6.1 | 7.7 | 12.8 | 17.0 | 178.0 | — | 0.19 | -66.9 | 42 | |
| DENTALKARTVASA DENTICITY LIMITED | 721 | 61.8 | — | — | — | 4.8 | 15.7 | -41.7 | — | — | 21° | |
| LAXMIDENTLLaxmi Dental Limited | 1,095 | 35.2 | 4.5 | 12.7 | 13.3 | 6.7 | 19.8 | — | 0.00 | -40.1 | 46 | |
| Sector medianof 7 shown | 1,785 | 54.8 | 5.6 | 10.1 | 13.3 | 17.0 | 19.8 | -17.6 | 0.19 | -16.3 | 46 |
Peer metrics from the latest filed quarters + EOD close · industry medians across the served industry
Who owns it and how that is changing: FIIs, mutual funds, promoters and the public, with delivery volume. Individual insider, bulk and block trades are in Activity.
Promoters hold 41.29% as of Aug 26.
Everything the company and its insiders file, in one feed: results, announcements, corporate actions, insider and SAST disclosures, bulk and block deals. 10 items on record; every PDF links to the exchange.
No scheduled events from filings.
Who runs it and how many people it employs. Annual reports, concall transcripts and credit ratings sit under Activity › Documents.
Molbio Diagnostics Limited is a mid-cap healthcare company traded on the NSE and BSE.
